Tuesday, October 17, 2017

Illumina Ventures Gets $230M For First Venture Capital Fund

San Francisco-based Illumina Ventures, an early-stage venture capital investor which was spun out of life sciences equipment maker Illumina, said Monday that it has raised $230M for its first fund. The fund is focused on genomics, and will invest in companies in the areas of life science research, clinical diagnostics, novel therapeutic platforms, and other technologies impacting human health. The fund launched in summer of 2016 with $100M from Illumina.